Heartflow is a medtech company revolutionizing cardiovascular care with its AI-powered, non-invasive heart imaging technology. The platform creates personalized 3D models of a patient’s coronary arteries from CT scans, enabling clinicians to assess blood flow and detect blockages without invasive procedures.
The company raised $316.7 million in its Nasdaq debut, backed by Bain Capital—reaching a $2.27 billion valuation as shares surged 47% on opening day. The IPO was priced at $19 per share, with the stock opening at $28 and peaking at $31.50.
Heartflow, headquartered in Mountain View, California, United States, was founded in 2007 by Charles A. Taylor, Christopher K. Zarins, and John Stevens. In 2017, the company joined the unicorn club. Its cutting-edge technology is rapidly becoming a preferred solution for hospitals and health systems seeking advanced, AI-driven cardiovascular diagnostics.